“The Potential Role of Soluble Angiotensin Converting Enzyme 2 As A Left Ventricular Dysfunction Biomarker”, J. Medicine, vol. 22, no. 2, pp. 127–131, Dec. 2021, doi: 10.3329/jom.v22i2.56702.